963
During and after IFN therapy we should consider the possibility of occurrence of IDDM as well as other autoimmune diseases and observe the clinical course carefully.
 IDDM as well as other autoimmune diseases: Effect; IFN therapy: Treatment; IFN therapy: Treatment.Drug; During and after: Treatment.Time_elapsed
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 IDDM as well as other autoimmune diseases: Effect; IFN therapy: Treatment; IFN therapy: Treatment.Drug; During and after: Treatment.Time_elapsed